1H NMR metabolomics investigation of an Alzheimer’s disease (AD) mouse model pinpoints important biochemical disturbances in brain and plasma
- 16 March 2013
- journal article
- Published by Springer Nature in Metabolomics
- Vol. 9 (5) , 974-983
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Assessment of two complementary liquid chromatography coupled to high resolution mass spectrometry metabolomics strategies for the screening of anabolic steroid treatment in calvesAnalytica Chimica Acta, 2011
- Quantification of High-Resolution1H NMR Spectra from Rat Brain ExtractsAnalytical Chemistry, 2010
- Metabolite identification via the Madison Metabolomics Consortium DatabaseNature Biotechnology, 2008
- Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extractsNature Protocols, 2007
- Metabolite concentrations of healthy mouse brain by Magnetic Resonance Spectroscopy at 7 Tesla2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 2005
- Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?Mechanisms of Ageing and Development, 2001
- Compartmentation of Brain Glutamate Metabolism in Neurons and GliaThe Journal of Nutrition, 2000
- Challenging the Cholinergic Hypothesis in Alzheimer DiseaseJAMA, 1999
- N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brainNeuroscience & Biobehavioral Reviews, 1989
- ATP and Brain FunctionJournal of Cerebral Blood Flow & Metabolism, 1989